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1. Introduction 
The development of conventional cytogenetic techniques in the 50’s leaded to a rapid 
increase of the knowledge on the etiology of malformation syndromes, being chromosomal 
anomalies reported as the most common genetic condition in humans (Pena, 1998). Around 
2-3% of newborns may have congenital malformations, and from those, just 20% have an 
established etiology (genetic or environmental), being 80% of these multifactorial or 
unknown (Stevenson & Hall, 2006). But this is only the tip of the iceberg, as probably half of 
the human concepts may have some kind of chromosomal defect (A. Boué & J. Boué, 1973), 
indicating that cytogenetic analysis is fundamental for the investigation of these cases. Since 
the 70’s, prenatal diagnosis for detecting cytogenetic abnormalities has become a routine 
procedure in many countries, and an important tool for the prevention of birth of 
handicapped children (A. Milunsky &  J. Milunsky, 1998). 
Cytogenetic analysis is an important component of invasive prenatal diagnosis as 
chromosomal abnormalities are detected in about 1 in 200 newborns and constitute a major 
cause of mental retardation and congenital malformations (Shaffer & Lupski, 2000). 
Microscopic chromosome analysis of cultured cells has been regarded as the gold standard 
method for prenatal diagnosis, since its first application to prenatal testing in 1966 by Steele 
and Breg (Steele & Breg, 1966) and the routine use of chromosome banding analysis in 1970s. 
Karyotyping has proved to be highly reliable for diagnosis of numerical chromosome 
abnormalities and structural rearrangements in fetal cells obtained invasively by either 
amniocentesis in the second trimester of pregnancy, or chorionic villus sampling (CVS) in the 
first trimester, since the early 1980s. The diagnostic accuracy of karyotyping fetal cells from 
cultured amniotic fluid (AF) has been found to be 99.4%-99.8%, and that of CVS 97.5-99.6%. 
However, the main limitation of karyotyping is the requirement of a cell culture, resulting in a 
period of 10-14 days for obtaining the final results (Bui, 2007). Furthermore, the success of cell 
culture depends on many factors: very good laboratory conditions for tissue culture, 
technician’s experience, and satisfactory cell growth with good quality of metaphases. 
Unfortunately, due to failure in one of these steps the whole process becomes jeopardized.  
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In the early 1980s, as better ultrasonographic imaging became available, the access to fetal 
blood was improved, and it could be obtained at about 18-20 weeks’ gestation from 
umbilical cord (cordocentesis) (Daffos,et al., 1983). Although blood sample allows rapid 
karyotyping within 72 hours, the gestational age at collection is already advanced, and in 
positive cases it would be too late for interruption. Besides, this procedure is associated with 
higher risk of complications than other prenatal diagnostic and, hence, has been performed 
only in selected cases (Daffos & Hobbins, 2002). 
When a fetus with multiple malformations is detected by ultrasound, the list of possible 
etiologies is very broad, and the possibility of a chromosomal anomaly is high. However, 
the result of a karyotype, so important for the clinical evaluation, is not always achieved. 
In some cases this is caused by the factors explained above, in others, due to death of the 
fetus before the initiation of any diagnostic investigation. In any case, it is very difficult to 
provide an appropriate genetic counseling without a karyotype result, and the family 
remains without information on the fetus condition and the risk for future pregnancies. 
This is a very unpleasant situation, and trying to find an alternative to decrease the 
anxiety of those families is the main goal of the strategy described below which involves 
the application of molecular techniques in different fetal materials to overcome this 
situation. 
2. Methodology 
We obtained different tissues from 50 multiple malformation fetuses distributed as: 
umbilical cord (15), lung (7), amniocytes (14) and paraffin embedded tissues (14). For 
traditional karyotypes, we used AF, UC and alternative materials from 115 fetuses, also with 
multiple malformations. The criteria for including the fetus as multiple malformations with 
indication for chromosomal aberrations were based on the “Catalogue of Unbalanced 
Chromosome Aberration in Man” (Schinzel, 2001). They are summarized in Table 1. 
 
 
Cleft palate, cleft lip, or both 
Esophageal atresia, TE fistula; anal atresia with fistula 
Malrotation of the gut, common mesentery; omphalocele 
Malformation of the heart and the great vessels 
Malformation of the kidney and urinary tract 
Certain brain malformation, particularly holoprosencephaly and agenesis of  
corpus callosum 
Absence or hypoplasia of radius and thumb 
Postaxial hexadactyly 
Microphtalmia, ocular coloboma 
Spina bifida (occipital or lumbar) 
  
Table 1. Common malformations in autosomal chromosomal aberrations 
2.1 DNA extraction 
The DNA from fresh tissues was extracted as described by Miller (Miller et al., 1988) with 
slight modifications. Tissue specimens were grinded before addition of the nuclei lysis buffer 
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and 1/10 of the reagent’s volume used for blood extraction was used. In a few cases (n=8) a 
commercial kit was used for DNA extraction. (NucleoSpin®Tissue from Macherey-Nagel). 
2.2 DNA extraction from paraffin embedded tissue  
This technique was adapted from Andreassen (Andreassen et al., 2004) and Coura (Coura et 
al., 2005) as follows: Paraffin block was sliced in small pieces between 5-10μ and 5 slices 
were placed into an ependorff. Xylol (1,5ml) was added and incubated for 30 minutes at 
37°C. Tubes were centrifuged at 14.000 rpm for 3 minutes. The supernatant was removed 
and all steps were repeated once. After the supernatant removal, samples were washed with 
70% Ethanol and centrifuged for 3 minutes at 7.200 rpm. This step was repeated twice and 
samples were left at room temperature for at least 30 minutes. After completely removal of 
the paraffin, 300 μl of Nuclei Lysis buffer, 20μl of SDS and 20μl of proteinase K were added. 
Samples were incubated for 3 days at 60°C and on the third day an extra volume of 5μl of 
proteinase K was added. The remaining steps for DNA precipitation were the same ones as 
described above for tissue DNA extraction. 
2.3 Multiplex ligation-dependent probe amplification (MLPA) 
Multiplex ligation-dependent probe amplification (MLPA) is a semiquantitatitive analysis 
based on polymerase chain reaction (PCR). It possesses many advantages such as high 
efficiency, simple operation, low cost and has been wildly applied in researches of diseases 
associated with copy number variation, point mutation and methylation (Zhou & Ren, 
2009). 
This new multiplex method is able to detect abnormal copy numbers of genomic DNA 
sequences requiring a minimum of 20ng of human DNA (Schouten et al., 2002). In this 
technique, it is not the nucleic acid, but the probes added to the samples that are 
amplified. MLPA allows discrimination of sequences that differ only in a single 
nucleotide, therefore MLPA can be used for detection of known mutation. It is basically a 
method to make a nuclei acid sample suitable for multiplex polymerase chain reaction 
(PCR) with the use of only one pair of primers. In the currently available kits, the 
products generated by PCR are separated by sequence-type electrophoresis. The 
thermocycler and sequencing-type electrophoresis equipment that are required, are 
present in most DNA diagnostic laboratories. Up to 96 samples can be handled 
simultaneously, 45 DNA sequences, and results can be obtained within 24 hours. One of 
the currently MLPA kits (P095, MRC-Holland, Amsterdam) is commercially available and 
contains eight independent probes for each of the chromosomes involved in almost 
frequent aneupolidies: 13, 18, 21, and X, and four Y-specific probes; and it is used as a 
rapid prenatal test by several medical centers on a large scale (Schouten et el., 2002). 
MLPA profiles must be compared with a similar profile obtained from a control DNA 
sample. Compared with a control reaction, the relative peak area of each amplification 
product reflects the relative copy number of the target sequence of that probe in the 
analyzed sample. An aberrant copy number of one or more of the sequences detected by 
MLPA probes can therefore be detected by a decrease or increase in relative peak area of 
the amplification products of the probes detecting those sequences.  
The length of the amplification product of each probe is different, and ranges in size 
between 130 and 480 nucleotides. This provides an optimal separation and low background 
on sequencing type electrophoresis gels. Although performing an MLPA reaction is easy, 
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the development of new MLPA assays is complex and time-consuming, and the success of 
the results depends basically on the quality of the DNA extraction. 
Briefly the protocol consists of: denaturing 20-500 ng of DNA by heating to 98°C in a 
thermocycler; adding the MLPA probes and leaving overnight at 60°C for hybridization. For 
the next step add the ligase and ligase buffer at 54°C for 15 min.(ligation of the two probe 
parts); inactivate the ligase by heating to 98°C; add PCR primers, dNTPs, and polymerase 
and start the PCR (amplification of probes).  The amplification products are separated by 
capillary electrophoresis. 
2.4 Quantitative Fluorescent-Polymerase Chain Reaction (QF-PCR) 
This method uses PCR amplification and fluorescent dye labeled primers targeting highly 
polymorphic regions of DNA sequence called short tandem repeats (STRs) that are located on 
the chromosomes of interest (Mansfield, 1993). Each target marker is specific to the 
chromosome on which it is located, thus the copy number of the STR marker reflects the copy 
number of the chromosome. Informative STR markers which exhibit a high heterogeneity have 
been selected so that copy number can be easily determined. A normal diploid sample has the 
normal complement of two of each of the somatic chromosomes, thus two alleles of a 
chromosome specific STR are determine by the QF-PCR technique as two peaks in a 1:1 ratio. 
The observation of an extra STR allele as either a three peak pattern in a 1:1:1 ratio or two peak 
pattern in a 2:1 ratio is diagnostic of a presence of an additional sequence which in turn may 
represent an additional chromosome, as in the case of a trisomy. 
Amplified products of the QF-PCR technique are analyzed quantitatively on a capillary 
Genetic Analyzer (ABI 3100) to determine the copy number of the analyzed STRs markers. 
The kit used in the study was from ELUCIGENE. The ELUCIGENE QSTR™ range of 
products are DNA based multiplexed assays for the rapid prenatal determination of 
aneuploidy status for the three most common autosomal trisomies and the sex 
chromosomes X and Y. PCR products are observed as a 5 dye labelled system using filter set 
G5. Filter set G5 detects the 6-FAM (blue), VIC (green), NED (yellow) and PET (red) labelled 
fragments plus the Size Standard marker labelled with LIZ (orange) on an 
electrophoretogram in the Genotyper program. 
The markers used are described in Tables 2 and 3. 
 
Marker Location Observed 
Heterozygosity 
Allele Size 
Range (bp) 
Marker Dye  
  Colour 
DXS981 Xq13.1 0.86 225-260 blue 
DXS1187 Xq26.2 0.72 122-170 green 
HPRT Xq26.2 0.78 265-300 green 
DXS7423 Xq28 0.74 372-388 green 
DXYS267 Xq21.3/Yp11.2 0.87 240-280 red 
AMEL Xp22.22/Yp11.2 - 104-110 yellow 
DXS6807 Xp22.32 0.70 331-351 blue 
DXS1283E Xp22.31 0.89 292-340 yellow 
SRY Yp11.31 - 244-251 yellow 
DYS448 Yq11.223 - 323-381 red 
 
Table 2. X and Y markers in ELUCIGENE QSTRs  
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Marker Location Observed  
Heterozygosity 
Allele Size 
 Range (bp) 
Marker Dye  
    Colour 
D13S252 13q12.2 0.85 260-330 red 
D13S305 13q13.3 0.75 418-470 green 
D13S628 13q31.1 0.69 425-472 yellow 
D13S634 13q21.33 0.81 355-440 blue 
D13S325 13q14.11 0.86 235-320 green 
D18S386 18q22.1 0.88 320-407 green 
D18S390 18q22.3 0.75 345-400 yellow 
D18S391 18q11.31 0.75 196-230 green 
D18S535 18q12.3 0.92 450-500 blue 
D18S819 18q11.2 0.70 370-450 red 
D18S978 18q12.3 0.67 180-230 yellow 
D21S11 21q21.1 0.90 220-283 blue 
D21S1437 21q21.1 0.84 283-350 blue 
D21S1409 21q21.2 0.81 160-220 red 
D21S1411 21q22.3 0.93 256-345 yellow 
D21S1435 21q21.3 0.75 152-210 blue 
Table 3. 13, 18 and 21 markers in ELUCIGENE QSTRs 
2.5 PCR Set Up 
PCR was performed according to the manufacturer’s instruction as described briefly: the 
thermal cycler is programmed for a single step cycle to activate the DNA polymerase at 
95°C, for 15 minutes, linked to an amplification cycling program of 30 seconds at 95°C 
(denaturation), 1 minute and 30 seconds at 59°C (annealing) and 1 minute and 30 seconds at 
72°C (extension) for 26 cycles. This should be linked to a 30 minutes time-delay at 72°C 
(extension) on the final cycle; sufficient vials should be separated to pre-aliquoted QSTR 
reaction mix for a number of samples and controls to be run. The vials are centrifuged at 
12,000g for 10 seconds; 2.5µl of test DNA is added to a sample vial containing QSTR reaction 
mix; the 95°C activation program is initiated (step 1). On completion of the amplification 
program the samples may be stored at room temperature overnight or at 2-8°C up to 7 days 
before analysis by capillary electrophoresis. 
Optimal results can be obtained using an ABI 3100 Genetic Analyzer  
We also obtained 115 samples from pregnant women with multiple malformations fetus, for 
traditional karyotype analysis. The biological samples obtained were: AF, UC and 
alternative materials, such as urine, cystic hygroma fluid, intraperitoneal or cerebrospinal 
fluids. AF and alternative materials were cultivated as long term culture, with Amniomax 
medium, at 37°C, in CO2 incubator. The blood culture (UC) was processed as short term 
culture (72hs) following standard cytogenetic procedures. 
3. Results 
We obtained 50 samples from different fetal materials for molecular techniques analysis, 
and 115 for traditional karyotyping (AF, UC, or alternative materials). All samples were 
from multiple malformations fetus without diagnosis. 
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For the molecular techniques, we first tested all the samples with the MLPA kit P095 and we 
observed that obtaining genetic profiles from samples containing minimal amounts of DNA 
can be difficult. Unfortunately, the quantity and quality of DNA was not adequate for this 
analysis and it was quite difficult to interpret the data obtained (the peak areas tend to be 
too variable when the DNA quality is not good enough). We then ran all samples again 
using QF-PCR. The XY test is very sensitive so that even when the quality of DNA was poor 
we could still determine the presence or absence of a Y chromosome. Thus, for some 
probands (09 cases), we could only give results for XY and not for autosomes. At times it 
was not possible to say whether the proband was 45,X or 46,XX since insufficient probes 
amplified, and the peaks were very weak  (Table 4).  
 
Case 
number 
Chr. 
21 
Chr. 
18 
Chr. 
13 
X / Y Interpretation/comments Traditional 
Karyotype 
01 2 2 2 XX No T13, 18, 21 detected  
02 2 2 3 XY Trisomy 13, meiotic error - 
03 2 2 2 XY No T13, 18, 21 detected  
04 2 2 2 XY No T13, 18, 21 detected  
05 - - - - Not enough DNA  
06 - - - XY Very weak peaks  
07 - - - XX No DNA left  
08 2 2 2 XX No T13, 18, 21 detected  
09 2 2 2 XY No T13, 18, 21 detected  
10 2 2 2 XX No T13, 18, 21 detected  
11 2 2 2 XY No T13, 18, 21 detected  
12 2 2 2 XY No T13, 18, 21 detected  
13 - - - XY Very weak peaks  
14 2 2 2 XX No T13, 18, 21 detected  
15 2 2 2 XY No T13, 18, 21 detected  
16 - - - XX Very weak peaks  
17 - - - XX Very weak peaks 46,XX 
18 2 2 2 XY No T13, 18, 21 detected  
19 2 2 2 XX No T13, 18, 21 detected  
20 - - - X/XX? Very weak peaks  
21 - - - XX Very weak peaks  
22 - - - XX Very weak peaks  
23 - - - - No peaks  
24 - - - XY? Very weak peaks  
25 - - - X/XX? Very weak peaks  
26 - - - - No peaks  
28 - - - - No peaks  
29 - - - - No peaks 46,XX 
30 - - - - No peaks 46,XY 
31 - - - - No peaks 47,XX+21 
32 - - - - No peaks  
33 - - - - No peaks  
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Case 
number 
Chr. 
21 
Chr. 
18 
Chr. 
13 
X / Y Interpretation/comments Traditional 
Karyotype 
37 - - - - No peaks  
38 - - - - No peaks 46,XX 
39 - - - - No peaks 45,X 
40 - - - - No peaks 46,XY 
41 - - - - No peaks  
42 - - - - No peaks  
43 - - - - No peaks  
44 - - - - No peaks  
45 - - - - No peaks  
46 - - - - No peaks  
47 2 3 2 XY Trisomy 18, meiotic error 47,XY,+18 
48 2 2 2 XX No T13, 18, 21 detected 46,XX 
49 - - - - No peaks 46,XX 
50 - - - XY Very weak peaks 47,XY+21 
51 - - - XY Very weak peaks 47,XY,+18 
52 2 3 2 XY Trisomy 18, meiotic error 47,XY,+18 
53 2 2 2 XX No T13, 18, 21 detected 47,XX,+mar 
54 2 2 2 XX No T13, 18, 21 detected 47,XX 
Table 4. Results of 50 samples from different tissues analyzes by Q-F PCR 
From the 50 cases, we could get partial results in 30. Although we had a very good 
technique for extracting DNA from paraffin (we’ve got enough DNA concentrations and 
relative good quality of DNA), this material showed to be inappropriate for molecular 
techniques, probably due to the formalin buffer used to embed the tissue at the time of 
collection. In all those cases we got no detectable peaks.  
In one case, the physician was quite sure about the clinical diagnosis of trisomy 13, and 
when the fetus died, his lung was collected for culture and karyotyping, and also umbilical 
cord for posterior DNA analysis. The lung culture failed, but we were able to apply QF-PCR 
in DNA extracted from UC and confirmed the clinical indication. In this case, three peaks 
were detected with markers D13S252, D13S305, D13S634 and D13S325. For marker D13S628 
we observed two peaks being one higher than the other indicating an extra allele.  
In two cases, trisomy 18 was detected, confirming the previous karyotyping. In one of the 
cases, three peaks were detected with marker D18S386 and D18S390, and two peaks, one 
being higher than the other, with markers D18S535 and D18S391. In the other case, three 
peaks were detected with marker D18S386, and two peaks detected, again one being higher 
than the other, with markers D18S391 and D18S978. 
From the floating amniocytes that did not adhere to the flask, and were collected at the first 
medium change (14 cases), we succeeded in extracting DNA and performed QF-PCR. This 
material would be normally discarded. From those, we were able to obtain eight molecular 
results from which two did not have a previous successful karyotype. 
The best results obtained for molecular analysis were from DNA extracted using a 
commercial kit as described before (Material and Methods). 
From 6 cases of aneuploidies that had previous karyotype, we were able to obtain two 
confirmations (cases number 47 and 52). On the other hand, for one case (case number 2) 
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which remained without karyotype, we obtained a positive result through QF-PCR. Case 
number 53 (table 4) could not be confirmed by molecular analysis because the origin of the 
extra chromosome marker was unknown and could not hybridize with the probes used. We 
had no discordant results between the molecular and traditional techniques for those cases 
were both analyses were performed. 
In Table 5, we describe the results from different sources of fetal material for karyotyping in 
115 multiple malformation fetuses. When, for some anatomical reason, AF CVS or UC could 
not be collected, the obstetrician strategy, sometimes for therapeutic reasons,  was the 
collection of alternative fetal material such as bladder drainage. Those biological materials 
could be also used for karyotying, and although there were few cases available, we had 
100% of culture success and karyotyping. 
 
Fetus sample Number of cases 
(n) 
Culture success 
(n) 
Success rate 
 (%) 
AF 87 83 95.5 
UC 15 14 93.3 
Alternative fluidsa 13 13 100 
TOTAL 115 110 95.6 
aBladder  (6), cystic hygroma  (2), intraperitoneal  (2), displastic kidney  (1), cystic lung  (1), 
cerebrospinal (1) fluids. 
Table 5. Different materials from multiple malformations fetus and success rate of cell 
cultures 
4. Discussion  
Cytogenetic analysis is an important tool for detecting chromosome abnormalities, once this 
is the cause of most common genetic disease in man (Pena, 1998). It has been very useful for 
prenatal diagnosis, and also in clinical genetics. However the traditional technique has some 
limitations, and in order to overcome these problems some new molecular and rapid 
techniques have been developed, such as QF-PCR and MLPA. In our study, we tried to use 
all possible biological sources obtained form the fetuses to be able to reach a diagnosis for a 
multiple malformation that could evolve to death, or had already died without any 
laboratory findings. The main limitation we wanted to overcome was to avoid the situation 
of leaving a multiple malformation fetus without a final diagnosis or karyotype which is a 
vital information for genetic counseling and for the family. Thus we tried to apply molecular 
techniques in postmortem or paraffin-embedded fetal tissues, or even non adhered 
amniocytes that would be normally discarded after culture.  
Karyotyping unconventional fetal samples, when obtaining traditional biological material is 
difficult, is not a very common approach in most laboratories (Donnenfeld et al., 2001; Gole 
et al., 1997). Nevertheless, we used this alternative whenever necessary, and achieved 100% 
success rate on a limited sample of 13 cases (Kessler et al., 2008), being this rate much higher 
when compared to other studies (Teoh et al., 1996; Donnenfeld, 2001). 
There is an ongoing debate whether Rapid Aneuploidy Diagnosis (RAD) should be 
employed as an adjunct to karyotyping or whether it could be used as a stand-alone test in 
selected groups of women (Leung et al., 2003; Cirigliano et al., 2006). The controversy is due 
to residual probability of a chromosome abnormality (both balanced and unbalanced) when 
RAD demonstrates a normal result. Few studies have estimated the residual risk of a 
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clinically significant chromosome aberration for different indications when RAD results are 
normal. In a meta-analysis of 12 studies involving invasive tests, the risk of having a 
chromosome aberration that was not expected to be detected by RAD methods, was 
estimated to be 0.9% (Leung & Lao, 2005). In our results, from 6 aneuploidies already 
diagnosed by karyotyping, only two cases (33.3%) were detected by QF-PCR, probably 
because of poor quality of DNA (mainly in paraffin). On the other hand, a third case 
detected by QF-PCR, had failed for tissue culture at the time of karyotyping analysis, the 
result was obtained only using molecular approaches. Little is known about the patients’ 
preference regarding the type of analysis to be performed. However in Sweden a research 
was made including 6000 women and 70% chose QF-PCR analysis alone (Bui, 2007). In our 
opinion, the combination of both techniques is safer, in order to overcome the particular 
limitations of each one. .  
MLPA has the same inherent limitations as those of QF-PCR in that it will not detect most 
structural chromosome aberrations, or balanced rearrangements such as translocations and 
inversions. Moreover, maternal cell contamination and 69,XXX triploidy will not be 
diagnosed by MLPA (Bui, 2007). In our study, for example, when a marker chromosome 
was detected by the traditional karyotype, the molecular techniques were not able to detect 
it, because the origin of the marker was unknown, so no specific probe could be applied. 
Although we developed a good protocol for extracting DNA from paraffin block wax, this 
material showed to be inappropriate for the molecular techniques used, as demonstrated in 
other studies which also needed smaller fragments of DNA (Halvarsson et al. 2004). 
Another study in postmortem tissues embedded in paraffin succeeded to obtain longer 
amplification fragments of around 300 bp using a specific treatment called pre-PCR 
restoration (Bonin et al., 2003), thus achieving better results. 
Whenever AF was set up for culture, not all amniocytes adhered to the bottom of the flask. 
After few days, by the first medium change, we observed that there were still a considerable 
number of floating cells, which could be used to obtain a considerable amount of DNA. We 
proposed and developed a protocol to extract DNA from those cells in order to guarantee a 
result independently of the cell culture success, and also to abbreviate the result with 
molecular techniques. Although we did not succeed as expected, we could obtain results 
from two cases when cell culture had failed. We could probably improve the success rate of 
these analyses by extracting DNA with commercial kits rather than in-house techniques in 
order to obtain better quality DNA, which is essential for the molecular analysis used here. 
The need of faster testing methods which do not require cell culture has been recognized by 
the scientific community to improve pregnancy management and alleviate parental anxiety 
(Nicolini et al., 2004). 
The best results obtained were from the last 8 cases, in which the DNA was extracted using 
a commercial kit. This is very important information and corroborates the fact that high 
quality DNA is necessary, from which we can obtain results even with degraded DNA 
(Roeder et al., 2009). 
5. Conclusion 
In conclusion, for follow up diagnostic testing, karyotyping has proved to be the gold 
standard method. This technology has remained essentially unchanged over 30 years, as no 
new technology has proven to be superior in terms of being able to detect such a wide range 
of abnormalities with the necessary precision (Slater et al., 2009). Nevertheless, molecular 
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testing, such as QF-PCR or MLPA, are becoming important alternatives in order to give a 
rapid result with low cost. Although these molecular techniques have some limitations, we 
did not find any discordant result, in comparison to traditional karyotype.  Nevertheless, the 
appropriate approach is always performing simultaneously both techniques. 
The importance of this study remains in the alternatives we proposed to give a final 
diagnosis to a multiple malformation fetus. We suggested some approaches to achieve a 
final laboratory result and deliver to the family the information they need to rebuild their 
lives, and make plans for their future, with the help of more rapid and efficient technology 
(RAD) and appropriate genetic counseling. 
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